Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)

the Alzheimer Precision Medicine Initiative (APMI); for the INSIGHT-preAD study group

doi:10.1186/s13195-022-01025-4

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)

the Alzheimer Precision Medicine Initiative (APMI), for the INSIGHT-preAD study group

Research output: Contribution to journal › Comment/debate

Abstract

Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, René S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Sid E. O’bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.

Original language	English
Article number	131
Journal	Alzheimer's Research and Therapy
Volume	14
Issue number	1
DOIs	https://doi.org/10.1186/s13195-022-01025-4
State	Published - 1 Dec 2022

Access to Document

10.1186/s13195-022-01025-4

Fingerprint

Dive into the research topics of 'Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)'. Together they form a unique fingerprint.

Cite this

the Alzheimer Precision Medicine Initiative (APMI), & for the INSIGHT-preAD study group (2022). Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). Alzheimer's Research and Therapy, 14(1), [131]. https://doi.org/10.1186/s13195-022-01025-4

the Alzheimer Precision Medicine Initiative (APMI) ; for the INSIGHT-preAD study group. / Correction : Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). In: Alzheimer's Research and Therapy. 2022 ; Vol. 14, No. 1.

@article{cf905da648884f22b042a8da98dd9933,

title = "Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)",

abstract = "Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, Ren{\'e} S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, St{\'e}phane Leh{\'e}ricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nistic{\`o}, Francis Nyasse-Messene, Sid E. O{\textquoteright}bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.",

author = "{the Alzheimer Precision Medicine Initiative (APMI)} and {for the INSIGHT-preAD study group} and Sakr, {Fatemah A.} and Grothe, {Michel J.} and Enrica Cavedo and Irina Jelistratova and Habert, {Marie Odile} and Martin Dyrba and Gabriel Gonzalez-Escamilla and Hugo Bertin and Maxime Locatelli and Stephane Lehericy and Stefan Teipel and Bruno Dubois and Harald Hampel and Hovagim Bakardjian and Habib Benali and Joel Bonheur and Laurie Boukadida and Nadia Boukerrou and Patrizia Chiesa and Olivier Colliot and Marion Dubois and St{\'e}phane Epelbaum and Geoffroy Gagliardi and Remy Genthon and Marion Houot and Aur{\'e}lie Kas and Foudil Lamari and Marcel Levy and Simone Lista and Christiane Metzinger and Fanny Mochel and Francis Nyasse and Catherine Poisson and Potier, {Marie Claude} and Marie Revillon and Antonio Santos and Andrade, {Katia Santos} and Marine Sole and Mohmed Surtee and {de Schotten}, {Michel Thiebaud} and Andrea Vergallo and Nadjia Younsi and Aguilar, {Lisi Flores} and Claudio Babiloni and Filippo Baldacci and Norbert Benda and Black, {Keith L.} and Bokde, {Arun L.W.} and Ubaldo Bonuccelli and O{\textquoteright}bryant, {Sid E.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

day = "1",

doi = "10.1186/s13195-022-01025-4",

language = "English",

volume = "14",

journal = "Alzheimer's Research and Therapy",

issn = "1758-9193",

publisher = "BioMed Central Ltd.",

number = "1",

}

the Alzheimer Precision Medicine Initiative (APMI) & for the INSIGHT-preAD study group 2022, 'Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)', Alzheimer's Research and Therapy, vol. 14, no. 1, 131. https://doi.org/10.1186/s13195-022-01025-4

Correction : Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). / the Alzheimer Precision Medicine Initiative (APMI); for the INSIGHT-preAD study group.

In: Alzheimer's Research and Therapy, Vol. 14, No. 1, 131, 01.12.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)

AU - the Alzheimer Precision Medicine Initiative (APMI)

AU - for the INSIGHT-preAD study group

AU - Sakr, Fatemah A.

AU - Grothe, Michel J.

AU - Cavedo, Enrica

AU - Jelistratova, Irina

AU - Habert, Marie Odile

AU - Dyrba, Martin

AU - Gonzalez-Escamilla, Gabriel

AU - Bertin, Hugo

AU - Locatelli, Maxime

AU - Lehericy, Stephane

AU - Teipel, Stefan

AU - Dubois, Bruno

AU - Hampel, Harald

AU - Bakardjian, Hovagim

AU - Benali, Habib

AU - Bonheur, Joel

AU - Boukadida, Laurie

AU - Boukerrou, Nadia

AU - Chiesa, Patrizia

AU - Colliot, Olivier

AU - Dubois, Marion

AU - Epelbaum, Stéphane

AU - Gagliardi, Geoffroy

AU - Genthon, Remy

AU - Houot, Marion

AU - Kas, Aurélie

AU - Lamari, Foudil

AU - Levy, Marcel

AU - Lista, Simone

AU - Metzinger, Christiane

AU - Mochel, Fanny

AU - Nyasse, Francis

AU - Poisson, Catherine

AU - Potier, Marie Claude

AU - Revillon, Marie

AU - Santos, Antonio

AU - Andrade, Katia Santos

AU - Sole, Marine

AU - Surtee, Mohmed

AU - de Schotten, Michel Thiebaud

AU - Vergallo, Andrea

AU - Younsi, Nadjia

AU - Aguilar, Lisi Flores

AU - Babiloni, Claudio

AU - Baldacci, Filippo

AU - Benda, Norbert

AU - Black, Keith L.

AU - Bokde, Arun L.W.

AU - Bonuccelli, Ubaldo

AU - O’bryant, Sid E.

PY - 2022/12/1

Y1 - 2022/12/1

N2 - Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, René S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Sid E. O’bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.

AB - Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, René S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Sid E. O’bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.

UR - http://www.scopus.com/inward/record.url?scp=85138384584&partnerID=8YFLogxK

U2 - 10.1186/s13195-022-01025-4

DO - 10.1186/s13195-022-01025-4

M3 - Comment/debate

C2 - 36104713

AN - SCOPUS:85138384584

SN - 1758-9193

VL - 14

JO - Alzheimer's Research and Therapy

JF - Alzheimer's Research and Therapy

IS - 1

M1 - 131

ER -

the Alzheimer Precision Medicine Initiative (APMI), for the INSIGHT-preAD study group. Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). Alzheimer's Research and Therapy. 2022 Dec 1;14(1):131. doi: 10.1186/s13195-022-01025-4

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this